Related Experiment Video
Updated: Jul 12, 2025

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
Should We Use Rifampicin in Periprosthetic Joint Infections Caused by Staphylococci When the Implant Has Been
Tobias Siegfried Kramer1,2,3, Alex Soriano4, Sarah Tedeschi5,6
1Institute for Hygiene and Environmental Medicine, Charité Universitätsmedizin Berlin, Berlin, Germany.
Background:
Previous studies demonstrated the efficacy of a rifampicin-based regimen in the treatment of acute staphylococcal periprosthetic joint infections (PJIs) treated with surgical debridement. However, evidence is lacking to support the use of rifampicin in cases where the implant is exchanged during revision.
Methods:
We included all consecutive cases of staphylococcal PJIs treated from January 2013 to December 2018 with revision surgery in this international, retrospective, multicenter observational cohort study. PJI was defined according to the European Bone and Joint Infection Society diagnostic criteria. A relapse or reinfection during follow-up, the need for antibiotic suppressive therapy, the need for implant removal, and PJI-related death were defined as clinical failure. Cases without reimplantation or with follow-up <12 months were excluded.
Results:
A total of 375 cases were included in the final analysis, including 124 1-stage exchanges (33.1%) and 251 2-stage exchanges (66.9%). Of those, 101 cases failed (26.9%). There was no statistically significant difference in failure of patients receiving rifampicin (22.5%, 42/187) and those not receiving rifampicin (31.4%, 59/188; P = .051). A subanalysis of chronic PJIs treated by 2-stage exchange arthroplasty demonstrated a lower failure rate in cases treated with rifampicin (15%) compared with the no-rifampicin group (35.5%; P = .005). In this subgroup, the use of rifampicin and an antibiotic holiday of >2 weeks were independent predictors of clinical success (odds ratio [OR], 0.36; 95% CI, 0.15-0.88; and OR, 0.19; 95% CI, 0.04-0.90; respectively).
Conclusions:
Combination treatment with rifampicin increases treatment success in patients with chronic staphylococcal PJI treated with 2-stage exchange arthroplasty.
Insights
Rifampicin improves outcomes for chronic staphylococcal periprosthetic joint infections (PJIs) undergoing two-stage exchange surgery. This combination therapy, along with an extended antibiotic holiday, significantly reduces treatment failure rates in these complex cases.
Area of Science:
- Orthopedics
- Infectious Diseases
- Pharmacology
Background:
- Staphylococcal periprosthetic joint infections (PJIs) are a significant complication of joint replacement surgery.
- Rifampicin-based regimens have shown efficacy in acute PJIs treated with debridement, but evidence for implant exchange is limited.
Purpose of the Study:
- To evaluate the efficacy of rifampicin in staphylococcal PJIs treated with revision surgery, specifically focusing on implant exchange.
- To identify predictors of clinical success in these challenging cases.
Main Methods:
- International, retrospective, multicenter observational cohort study of 375 patients with staphylococcal PJIs undergoing revision surgery (January 2013-December 2018).
- PJI diagnosis based on European Bone and Joint Infection Society criteria.
- Clinical failure defined as relapse, reinfection, need for suppressive therapy, implant removal, or PJI-related death.
Main Results:
- No significant difference in failure rates between rifampicin and no-rifampicin groups overall (22.5% vs. 31.4%).
- In chronic PJIs treated with 2-stage exchange, rifampicin use was associated with a significantly lower failure rate (15% vs. 35.5%, P = .005).
- Rifampicin use and an antibiotic holiday >2 weeks were independent predictors of success in the 2-stage exchange subgroup.
Conclusions:
- Combination treatment with rifampicin enhances treatment success in patients with chronic staphylococcal PJI undergoing 2-stage exchange arthroplasty.
- Extended antibiotic holidays are also crucial for successful outcomes in these cases.
More Related Videos
Related Concept Videos
Bacterial Signaling
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Mitral Stenosis III: Medical Management

